Elizabeth Sidhartha
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Elizabeth Sidhartha has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
- Arli Aditya Parikesit
Department of Bioinformatics, School of Life Sciences, Indonesia International Institute for Life Sciences
2 shared publications Ernst Richard Ng
Department of Biomedicine, School of Health and Life Sciences Jakarta i3L University
2 shared publicationsI Made Artika
Biomolecule Division, Department of Biochemistry Bogor West Java IPB University
2 shared publicationsIrene Nathania Christiawan
Department of Biomedicine, School of Health and Life Sciences Jakarta i3L University
2 shared publications- Mega Safithri
Department of Biochemistry, Faculty of Mathematics and Natural Science, IPB University, Dramaga Campus, Bogor 16680, Indonesia
2 shared publications Okti Nadia Poetri
Department of Infectious Diseases and Public Health, School of Veterinary Medicine and Biomedical Sciences Bogor West Java IPB University
2 shared publications
Latest Publications
- Open Access
- 21 August 2026
- Published by F1000 Research Ltd in F1000Research
- Vol. 15, 1073
High-Quality Draft Genome Sequence of Endophytic Kluyvera Ascorbata Strain PCL31 Isolated from Piper Crocatum (red betel)
Endophytic bacteria within medicinal plants are a largely untapped reservoir of bioactive compounds and adaptive genetic traits. Piper crocatum (red betel), a Southeast Asian medicinal herb rich in flavonoids, alkaloids, and phenolics, offers a chemically selective niche for endophytes, yet the genomes of its microbial associates remain poorly characterised. Kluyvera ascorbata occurs as a plant-associated endophyte and an opportunistic human pathogen, and its chromosomal bla KLUA gene is the recognised progenitor of the clinically important CTX-M-2 β-lactamase sublineage. We report a high-quality draft genome of endophytic strain PCL31, isolated from surface-sterilised Piper crocatum tissues collected in Bogor, Indonesia. Whole-genome sequencing used the Oxford Nanopore PromethION platform, with de novo assembly in Flye, polishing in Medaka, and quality assessment by QUAST and BUSCO. The assembly spans 4,978,299 bp across eight contigs (N50 1.45 Mbp; GC content 54.26%; 100% BUSCO completeness, enterobacterales_odb10 , n = 440). Species identity was confirmed by digital DNA–DNA hybridisation (dDDH 88.6% against the type strain K. ascorbata ATCC 33433) and average nucleotide identity (ANI 98.6% against reference genome NZ_CP096201.1). Annotation identified 4,579 protein-coding sequences, 22 ribosomal RNA, 88 transfer RNA, and 81 non-coding RNA genes, and no CRISPR/Cas systems. antiSMASH 8.0 predicted four biosynthetic gene clusters (BGCs): a 53.8 kb non-ribosomal peptide synthetase (NRPS)–metallophore cluster matching the conserved enterobactin locus (MIBiG similarity 0.83), plus three low-similarity clusters (≤ 0.50) of uncertain novelty — a ribosomally synthesised and post-translationally modified peptide (RiPP)-like cluster, a terpene-precursor cluster, and an azole-containing RiPP. CARD-RGI profiling returned one Perfect hit ( bla CTX-M-2) and 25 Strict hits, the latter dominated by intrinsic Enterobacteriaceae efflux and target-modification genes; phenotypic confirmation was not performed. This genome provides a resource for bioprospecting secondary metabolites from medicinal-plant endophytes and underscores the value of plant-associated isolates for biosafety and antimicrobial-resistance surveillance in opportunistic pathogens.
- 21 August 2026
- Published by F1000 Research Ltd in F1000Research
- Vol. 15, 1073
Open AccessHigh-Quality Draft Genome Sequence of Endophytic Kluyvera Ascorbata Strain PCL31 Isolated from Piper Crocatum (red betel)
Endophytic bacteria within medicinal plants are a largely untapped reservoir of bioactive compounds and adaptive genetic traits. Piper crocatum (red betel), a Southeast Asian medicinal herb rich in flavonoids, alkaloids, and phenolics, offers a chemically selective niche for endophytes, yet the genomes of its microbial associates remain poorly characterised. Kluyvera ascorbata occurs as a plant-associated endophyte and an opportunistic human pathogen, and its chromosomal bla KLUA gene is the recognised progenitor of the clinically important CTX-M-2 β-lactamase sublineage. We report a high-quality draft genome of endophytic strain PCL31, isolated from surface-sterilised Piper crocatum tissues collected in Bogor, Indonesia. Whole-genome sequencing used the Oxford Nanopore PromethION platform, with de novo assembly in Flye, polishing in Medaka, and quality assessment by QUAST and BUSCO. The assembly spans 4,978,299 bp across eight contigs (N50 1.45 Mbp; GC content 54.26%; 100% BUSCO completeness, enterobacterales_odb10 , n = 440). Species identity was confirmed by digital DNA–DNA hybridisation (dDDH 88.6% against the type strain K. ascorbata ATCC 33433) and average nucleotide identity (ANI 98.6% against reference genome NZ_CP096201.1). Annotation identified 4,579 protein-coding sequences, 22 ribosomal RNA, 88 transfer RNA, and 81 non-coding RNA genes, and no CRISPR/Cas systems. antiSMASH 8.0 predicted four biosynthetic gene clusters (BGCs): a 53.8 kb non-ribosomal peptide synthetase (NRPS)–metallophore cluster matching the conserved enterobactin locus (MIBiG similarity 0.83), plus three low-similarity clusters (≤ 0.50) of uncertain novelty — a ribosomally synthesised and post-translationally modified peptide (RiPP)-like cluster, a terpene-precursor cluster, and an azole-containing RiPP. CARD-RGI profiling returned one Perfect hit ( bla CTX-M-2) and 25 Strict hits, the latter dominated by intrinsic Enterobacteriaceae efflux and target-modification genes; phenotypic confirmation was not performed. This genome provides a resource for bioprospecting secondary metabolites from medicinal-plant endophytes and underscores the value of plant-associated isolates for biosafety and antimicrobial-resistance surveillance in opportunistic pathogens.
- Open Access
- 6 July 2026
- Published by F1000 Research Ltd in F1000Research
- Vol. 15, 1073
High-quality draft genome sequence of endophytic Kluyvera ascorbata strain PCL31 isolated from Piper crocatum (red betel)
Endophytic bacteria within medicinal plants are a largely untapped reservoir of bioactive compounds and adaptive genetic traits. Piper crocatum (red betel), a Southeast Asian medicinal herb rich in flavonoids, alkaloids, and phenolics, offers a chemically selective niche for endophytes, yet the genomes of its microbial associates remain poorly characterised. Kluyvera ascorbata occurs as a plant-associated endophyte and an opportunistic human pathogen, and its chromosomal bla KLUA gene is the recognised progenitor of the clinically important CTX-M-2 β-lactamase sublineage. We report a high-quality draft genome of endophytic strain PCL31, isolated from surface-sterilised Piper crocatum tissues collected in Bogor, Indonesia. Whole-genome sequencing used the Oxford Nanopore PromethION platform, with de novo assembly in Flye, polishing in Medaka, and quality assessment by QUAST and BUSCO. The assembly spans 4,978,299 bp across eight contigs (N50 1.45 Mbp; GC content 54.26%; 100% BUSCO completeness, enterobacterales_odb10 , n = 440). Species identity was confirmed by digital DNA–DNA hybridisation (dDDH 88.6% against the type strain K. ascorbata ATCC 33433) and average nucleotide identity (ANI 98.6% against reference genome NZ_CP096201.1). Annotation identified 4,579 protein-coding sequences, 22 ribosomal RNA, 88 transfer RNA, and 81 non-coding RNA genes, and no CRISPR/Cas systems. antiSMASH 8.0 predicted four biosynthetic gene clusters (BGCs): a 53.8 kb non-ribosomal peptide synthetase (NRPS)–metallophore cluster matching the conserved enterobactin locus (MIBiG similarity 0.83), plus three low-similarity clusters (≤ 0.50) of uncertain novelty — a ribosomally synthesised and post-translationally modified peptide (RiPP)-like cluster, a terpene-precursor cluster, and an azole-containing RiPP. CARD-RGI profiling returned one Perfect hit ( bla CTX-M-2) and 25 Strict hits, the latter dominated by intrinsic Enterobacteriaceae efflux and target-modification genes; phenotypic confirmation was not performed. This genome provides a resource for bioprospecting secondary metabolites from medicinal-plant endophytes and underscores the value of plant-associated isolates for biosafety and antimicrobial-resistance surveillance in opportunistic pathogens.
- 6 July 2026
- Published by F1000 Research Ltd in F1000Research
- Vol. 15, 1073
Open AccessHigh-quality draft genome sequence of endophytic Kluyvera ascorbata strain PCL31 isolated from Piper crocatum (red betel)
Endophytic bacteria within medicinal plants are a largely untapped reservoir of bioactive compounds and adaptive genetic traits. Piper crocatum (red betel), a Southeast Asian medicinal herb rich in flavonoids, alkaloids, and phenolics, offers a chemically selective niche for endophytes, yet the genomes of its microbial associates remain poorly characterised. Kluyvera ascorbata occurs as a plant-associated endophyte and an opportunistic human pathogen, and its chromosomal bla KLUA gene is the recognised progenitor of the clinically important CTX-M-2 β-lactamase sublineage. We report a high-quality draft genome of endophytic strain PCL31, isolated from surface-sterilised Piper crocatum tissues collected in Bogor, Indonesia. Whole-genome sequencing used the Oxford Nanopore PromethION platform, with de novo assembly in Flye, polishing in Medaka, and quality assessment by QUAST and BUSCO. The assembly spans 4,978,299 bp across eight contigs (N50 1.45 Mbp; GC content 54.26%; 100% BUSCO completeness, enterobacterales_odb10 , n = 440). Species identity was confirmed by digital DNA–DNA hybridisation (dDDH 88.6% against the type strain K. ascorbata ATCC 33433) and average nucleotide identity (ANI 98.6% against reference genome NZ_CP096201.1). Annotation identified 4,579 protein-coding sequences, 22 ribosomal RNA, 88 transfer RNA, and 81 non-coding RNA genes, and no CRISPR/Cas systems. antiSMASH 8.0 predicted four biosynthetic gene clusters (BGCs): a 53.8 kb non-ribosomal peptide synthetase (NRPS)–metallophore cluster matching the conserved enterobactin locus (MIBiG similarity 0.83), plus three low-similarity clusters (≤ 0.50) of uncertain novelty — a ribosomally synthesised and post-translationally modified peptide (RiPP)-like cluster, a terpene-precursor cluster, and an azole-containing RiPP. CARD-RGI profiling returned one Perfect hit ( bla CTX-M-2) and 25 Strict hits, the latter dominated by intrinsic Enterobacteriaceae efflux and target-modification genes; phenotypic confirmation was not performed. This genome provides a resource for bioprospecting secondary metabolites from medicinal-plant endophytes and underscores the value of plant-associated isolates for biosafety and antimicrobial-resistance surveillance in opportunistic pathogens.
- Open Access
- 1 December 2025
- Published by Journal of Pure and Applied Microbiology in Journal of Pure and Applied Microbiology
- Vol. 19 (4) , 3039-3047
Plasmodium falciparum Drug Resistance Single Nucleotide Polymorphism Analysis Pipeline Based on Southeast Asian Genetic Samples
Drug resistance in pathogens represents an escalating global health challenge, particularly in Plasmodium falciparum, the causative agent of malaria. The emergence of drug-resistant strains complicates treatment and highlights the need for rapid and accurate detection methods. In P. falciparum, resistance has been largely attributed to single nucleotide polymorphisms (SNPs) in key genes such as PfMDR1, PfKelch13, and PfCRT, which are associated with resistance to artemisinin-based combination therapies and chloroquine—two mainstays of antimalarial treatment. This study aimed to develop a bioinformatics pipeline capable of analyzing P. falciparum genomic sequences to detect and annotate SNPs that may confer drug resistance. The pipeline was implemented on the Galaxy online analysis platform using its workflow function. It processes both reference and sample sequences through alignment, mutation detection, SNP selection, and annotation based on a reference general feature format. Although no SNPs were identified directly within known drug resistance genes in the analyzed samples, the developed pipeline successfully detected and annotated SNPs across the chromosomes containing these genes. This approach provides a practical framework for future applications in point-of-care detection and surveillance of drug-resistant P. falciparum strains.
- 1 December 2025
- Published by Journal of Pure and Applied Microbiology in Journal of Pure and Applied Microbiology
- Vol. 19 (4) , 3039-3047
Open AccessPlasmodium falciparum Drug Resistance Single Nucleotide Polymorphism Analysis Pipeline Based on Southeast Asian Genetic Samples
Drug resistance in pathogens represents an escalating global health challenge, particularly in Plasmodium falciparum, the causative agent of malaria. The emergence of drug-resistant strains complicates treatment and highlights the need for rapid and accurate detection methods. In P. falciparum, resistance has been largely attributed to single nucleotide polymorphisms (SNPs) in key genes such as PfMDR1, PfKelch13, and PfCRT, which are associated with resistance to artemisinin-based combination therapies and chloroquine—two mainstays of antimalarial treatment. This study aimed to develop a bioinformatics pipeline capable of analyzing P. falciparum genomic sequences to detect and annotate SNPs that may confer drug resistance. The pipeline was implemented on the Galaxy online analysis platform using its workflow function. It processes both reference and sample sequences through alignment, mutation detection, SNP selection, and annotation based on a reference general feature format. Although no SNPs were identified directly within known drug resistance genes in the analyzed samples, the developed pipeline successfully detected and annotated SNPs across the chromosomes containing these genes. This approach provides a practical framework for future applications in point-of-care detection and surveillance of drug-resistant P. falciparum strains.
- Open Access
- 29 December 2023
- Published by Narra Sains Indonesia in Narra J
- Vol. 3 (3) , e301
Designing hybrid CRISPR-Cas12 and LAMP detection systems for treatment-resistant Plasmodium falciparum with in silico method
Genes associated with drug resistance of first line drugs for Plasmodium falciparum have been identified and characterized of which three genes most commonly associated with drug resistance are P. falciparum chloroquine resistance transporter gene (PfCRT), P. falciparum multidrug drug resistance gene 1 (PfMDR1), and P. falciparum Kelch protein K13 gene (PfKelch13). Polymorphism in these genes could be used as molecular markers for identifying drug resistant strains. Nucleic acid amplification test (NAAT) along with DNA sequencing is a powerful diagnostic tool that could identify these polymorphisms. However, current NAAT and DNA sequencing technologies require specific instruments which might limit its application in rural areas. More recently, a combination of isothermal amplification and CRISPR detection system showed promising results in detecting mutations at a nucleic acid level. Moreover, the Loop-mediated isothermal amplification (LAMP)-CRISPR systems offer robust and straightforward detection, enabling it to be deployed in rural and remote areas. The aim of this study was to develop a novel diagnostic method, based on LAMP of targeted genes, that would enable the identification of drug-resistant P. falciparum strains. The methods were centered on sequence analysis of P. falciparum genome, LAMP primers design, and CRISPR target prediction. Our designed primers are satisfactory for identifying polymorphism associated with drug resistant in PfCRT, PfMDR1, and PfKelch13. Overall, the developed system is promising to be used as a detection method for P. falciparum treatment-resistant strains. However, optimization and further validation the developed CRISPR-LAMP assay are needed to ensure its accuracy, reliability, and feasibility
- 29 December 2023
- Published by Narra Sains Indonesia in Narra J
- Vol. 3 (3) , e301
Open AccessDesigning hybrid CRISPR-Cas12 and LAMP detection systems for treatment-resistant Plasmodium falciparum with in silico method
Genes associated with drug resistance of first line drugs for Plasmodium falciparum have been identified and characterized of which three genes most commonly associated with drug resistance are P. falciparum chloroquine resistance transporter gene (PfCRT), P. falciparum multidrug drug resistance gene 1 (PfMDR1), and P. falciparum Kelch protein K13 gene (PfKelch13). Polymorphism in these genes could be used as molecular markers for identifying drug resistant strains. Nucleic acid amplification test (NAAT) along with DNA sequencing is a powerful diagnostic tool that could identify these polymorphisms. However, current NAAT and DNA sequencing technologies require specific instruments which might limit its application in rural areas. More recently, a combination of isothermal amplification and CRISPR detection system showed promising results in detecting mutations at a nucleic acid level. Moreover, the Loop-mediated isothermal amplification (LAMP)-CRISPR systems offer robust and straightforward detection, enabling it to be deployed in rural and remote areas. The aim of this study was to develop a novel diagnostic method, based on LAMP of targeted genes, that would enable the identification of drug-resistant P. falciparum strains. The methods were centered on sequence analysis of P. falciparum genome, LAMP primers design, and CRISPR target prediction. Our designed primers are satisfactory for identifying polymorphism associated with drug resistant in PfCRT, PfMDR1, and PfKelch13. Overall, the developed system is promising to be used as a detection method for P. falciparum treatment-resistant strains. However, optimization and further validation the developed CRISPR-LAMP assay are needed to ensure its accuracy, reliability, and feasibility
- 2 August 2017
- Published by Taylor & Francis in Natural Product Research
- Vol. 32 (17) , 2067-2070
Evaluation of antiplasmodial properties of a cyanobacterium, Spirulina platensis and its mechanism of action
The rapid emergence of antimalarial drug resistance necessitates a continual effort on novel drug discovery. A cyanobacterium, Spirulina platensis, is a potential antimalarial agent that has been widely consumed as food supplement in the form of crude extract. It is known to possess antiviral, antibacterial and antifungi activities. This study examined the antimalarial activities of several Spirulina formulas against Plasmodium falciparum 3D7, in vitro. The tested Spirulina formulas included commercially available capsule, crude extract and alkaloid fraction. Results showed that all tested formula possessed antimalarial activities with the Spirulina capsule exhibited the highest activities (IC50 = 2.16 μg/mL). Light and electron microscopies revealed interference of the Spirulina with the parasite hemozoin formation. In conclusion, all tested Spirulina formulas and fraction exhibited moderate to high antimalarial activities.
- 2 August 2017
- Published by Taylor & Francis in Natural Product Research
- Vol. 32 (17) , 2067-2070
Evaluation of antiplasmodial properties of a cyanobacterium, Spirulina platensis and its mechanism of action
The rapid emergence of antimalarial drug resistance necessitates a continual effort on novel drug discovery. A cyanobacterium, Spirulina platensis, is a potential antimalarial agent that has been widely consumed as food supplement in the form of crude extract. It is known to possess antiviral, antibacterial and antifungi activities. This study examined the antimalarial activities of several Spirulina formulas against Plasmodium falciparum 3D7, in vitro. The tested Spirulina formulas included commercially available capsule, crude extract and alkaloid fraction. Results showed that all tested formula possessed antimalarial activities with the Spirulina capsule exhibited the highest activities (IC50 = 2.16 μg/mL). Light and electron microscopies revealed interference of the Spirulina with the parasite hemozoin formation. In conclusion, all tested Spirulina formulas and fraction exhibited moderate to high antimalarial activities.